Evaluation of Myo-Inositol as a Potential Biomarker for Depression in Schizophrenia

Depression is highly prevalent in patients with schizophrenia and is associated with significant clinical consequences, but there is no known biomarker for depression in schizophrenia. One of the putative neurochemical biomarkers for depression in major depressive disorder (MDD) is reduced cerebral...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuropsychopharmacology
Asıl Yazarlar: Chiappelli, Joshua, Rowland, Laura M, Wijtenburg, S Andrea, Muellerklein, Florian, Tagamets, Malle, McMahon, Robert P, Gaston, Frank, Kochunov, Peter, Hong, L Elliot
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2015
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4613604/
https://ncbi.nlm.nih.gov/pubmed/25722115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2015.57
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller